Global Point of Care Diagnostic and Testing Market Growth (Status and Outlook) 2024-2030

2024

Global Point of Care Diagnostic and Testing Market Growth (Status and Outlook) 2024-2030

Name: Global Point of Care Diagnostic and Testing Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001483
Price: 3450 USD
Availability: InStock
Rating: 5 (16 reviews)

The global Point of Care Diagnostic and Testing market, valued at US$ 44,620 million in 2023, is growing with the rising demand for convenient and rapid medical testing solutions.

Bonafide Trust
22-10-2024
Pages : 124
Figures : 81
Tables : 141
Region : Global
Category : Lifescience & Healthcare
Healthcare

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global point of care (POC) diagnostics and testing market is a rapidly growing segment within the healthcare industry, driven by the increasing demand for immediate, accurate, and accessible diagnostic solutions. This market encompasses a wide range of products, including glucose monitoring devices, infectious disease testing kits, cardiometabolic disease testing kits, pregnancy and fertility testing kits, and hematology testing kits. The market is expected to grow significantly, with a projected compound annual growth rate (CAGR) of 6.2% from 2024 to 2030, reaching a value of USD 51.19 billion by 2030. Key factors driving this growth include the rising prevalence of chronic diseases, the aging population, and the need for decentralized healthcare solutions. POC diagnostic tests offer several advantages, such as rapid results, ease of use, and the ability to perform tests at or near the site of patient care, which enhances patient outcomes and reduces healthcare costs. The market is also influenced by technological advancements, regulatory approvals, and the increasing adoption of mobile health (mHealth) applications. North America currently dominates the market, followed by Europe and Asia-Pacific, with emerging markets in Latin America, the Middle East, and Africa showing significant potential for growth. The global POC diagnostics and testing market is poised to play a crucial role in transforming healthcare delivery, offering promising solutions for improving accessibility, efficiency, and quality of care. The research report provides analysis of the competitive landscape within the Point of Care Diagnostic and Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. The research report can delve into the latest technological developments in the Point of Care Diagnostic and Testing industry. This include advancements in Point of Care Diagnostic and Testing technology, Point of Care Diagnostic and Testing new entrants, Point of Care Diagnostic and Testing new investment, and other innovations that are shaping the future of Point of Care Diagnostic and Testing.

According to Publisher, the global Point of Care Diagnostic and Testing market size was valued at US$ 44620 million in 2023. With growing demand in downstream market, the Point of Care Diagnostic and Testing is forecast to a readjusted size of US$ 93830 million by 2030 with a CAGR of 11.2% during review period. The research report highlights the growth potential of the global Point of Care Diagnostic and Testing market. Point of Care Diagnostic and Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point of Care Diagnostic and Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point of Care Diagnostic and Testing market. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The report can identify and analyse the factors driving the growth of the Point of Care Diagnostic and Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The Global Point of Care The diagnostic and Testing market is segmented by type into various categories, including Glucose Testing, Infectious Disease Testing, Cardiac Marker Testing, Pregnancy and Fertility Testing, Hematology Testing, Coagulation Testing, Cholesterol Testing, urine Testing, and Drug-of-Abuse Testing. Each segment caters to specific healthcare needs and applications. Glucose Testing is crucial for diabetes management, providing rapid results for blood sugar levels. Infectious Disease Testing includes rapid tests for diseases like HIV, influenza, and hepatitis, enabling timely diagnosis and treatment. Cardiac Marker Testing helps in the early detection of heart conditions by measuring specific proteins in the blood. Pregnancy and Fertility Testing offers quick results for pregnancy detection and ovulation prediction. Hematology Testing involves analyzing blood samples to diagnose conditions like anemia and infections. Coagulation Testing assesses blood clotting disorders, while Cholesterol Testing monitors lipid levels to prevent cardiovascular diseases. Urinalysis Testing detects abnormalities in urine, and Drug-of-Abuse Testing identifies the presence of illicit substances. These segments collectively contribute to the comprehensive and efficient diagnosis and monitoring of various health conditions, enhancing patient care and outcomes.

The Global Point of Care The diagnostic and testing market is segmented by application into various categories, including hospitals and clinics, physician offices, ambulatory care settings, home care, diagnostic laboratories, and research institutes. Each segment caters to specific healthcare needs and applications. Hospitals and clinics are the primary users of point-of-care diagnostics, utilizing these tests for rapid diagnosis and treatment decisions. Physician offices use point-of-care testing to provide immediate results to patients, enhancing the efficiency of patient care. Ambulatory care settings such as urgent care centers and retail clinics also rely on point-of-care diagnostics for quick and accurate testing. Home care involves patients and caregivers using point-of-care tests for monitoring chronic conditions and managing health at home. Diagnostic laboratories use these tests for a wide range of applications, including infectious disease testing and genetic analysis. Research institutes utilize point-of-care diagnostics for clinical trials and research studies, contributing to the development of new diagnostic technologies and treatments. These segments collectively contribute to the comprehensive and efficient diagnosis and monitoring of various health conditions, enhancing patient care and outcomes.

The global point-of-care diagnostic and testing market is segmented regionally into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America currently dominates the market, primarily driven by several key factors. Firstly, the region boasts a highly advanced healthcare infrastructure with cutting-edge technology and well-established healthcare systems. Secondly, the prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases is significantly high, creating a substantial demand for rapid and accurate diagnostic solutions. Thirdly, substantial investments are consistently made in healthcare research and development, fostering innovation and the adoption of new technologies, including point-of-care diagnostics. Europe closely follows North America, characterized by a strong emphasis on innovation and a supportive regulatory environment for point-of-care diagnostics. European countries have a long history of medical advancements and a robust healthcare system, driving the development and adoption of novel diagnostic technologies. Furthermore, stringent regulatory frameworks ensure the safety and efficacy of these devices, boosting patient confidence and market growth.

The Asia-Pacific region is witnessing rapid growth in the point-of-care diagnostics market, fueled by a convergence of factors. Increasing healthcare expenditure, driven by rising disposable incomes and government initiatives, is a major contributor. Growing awareness among the population regarding the benefits of early disease detection and preventive healthcare is also significantly impacting market demand. Moreover, the region is experiencing a rapid rise in its geriatric population, leading to an increased need for convenient and accessible diagnostic solutions for age-related conditions. Latin America and the Middle East & Africa are emerging markets with significant growth potential. In these regions, increasing government initiatives to improve healthcare access and affordability are driving the adoption of point-of-care diagnostics. Furthermore, rising healthcare needs, driven by factors such as increasing prevalence of infectious diseases, growing incidence of chronic diseases, and the need for improved disease surveillance, are creating a strong demand for these technologies. These regional differences in market dynamics are a reflection of diverse healthcare needs, varying economic conditions, and the pace of technological advancements across different regions. These factors collectively shape the global point-of-care diagnostics landscape, influencing market growth, innovation, and the availability of these critical tools for healthcare delivery.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point of Care Diagnostic and Testing Market Size 2019-2030
2.1.2 Point of Care Diagnostic and Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Point of Care Diagnostic and Testing Segment by Type
2.2.1 Device
2.2.2 Consumables
2.2.3 Others
2.3 Point of Care Diagnostic and Testing Market Size by Type
2.3.1 Point of Care Diagnostic and Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Point of Care Diagnostic and Testing Market Size Market Share by Type (2019-2024)
2.4 Point of Care Diagnostic and Testing Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home
2.4.4 Others
2.5 Point of Care Diagnostic and Testing Market Size by Application
2.5.1 Point of Care Diagnostic and Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Point of Care Diagnostic and Testing Market Size Market Share by Application (2019-2024)
3 Point of Care Diagnostic and Testing Market Size by Player
3.1 Point of Care Diagnostic and Testing Market Size Market Share by Players
3.1.1 Global Point of Care Diagnostic and Testing Revenue by Players (2019-2024)
3.1.2 Global Point of Care Diagnostic and Testing Revenue Market Share by Players (2019-2024)
3.2 Global Point of Care Diagnostic and Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Point of Care Diagnostic and Testing by Regions
4.1 Point of Care Diagnostic and Testing Market Size by Regions (2019-2024)
4.2 Americas Point of Care Diagnostic and Testing Market Size Growth (2019-2024)
4.3 APAC Point of Care Diagnostic and Testing Market Size Growth (2019-2024)
4.4 Europe Point of Care Diagnostic and Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Point of Care Diagnostic and Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Point of Care Diagnostic and Testing Market Size by Country (2019-2024)
5.2 Americas Point of Care Diagnostic and Testing Market Size by Type (2019-2024)
5.3 Americas Point of Care Diagnostic and Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point of Care Diagnostic and Testing Market Size by Region (2019-2024)
6.2 APAC Point of Care Diagnostic and Testing Market Size by Type (2019-2024)
6.3 APAC Point of Care Diagnostic and Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Point of Care Diagnostic and Testing by Country (2019-2024)
7.2 Europe Point of Care Diagnostic and Testing Market Size by Type (2019-2024)
7.3 Europe Point of Care Diagnostic and Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Point of Care Diagnostic and Testing by Region (2019-2024)
8.2 Middle East & Africa Point of Care Diagnostic and Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Point of Care Diagnostic and Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Point of Care Diagnostic and Testing Market Forecast
10.1 Global Point of Care Diagnostic and Testing Forecast by Regions (2025-2030)
10.1.1 Global Point of Care Diagnostic and Testing Forecast by Regions (2025-2030)
10.1.2 Americas Point of Care Diagnostic and Testing Forecast
10.1.3 APAC Point of Care Diagnostic and Testing Forecast
10.1.4 Europe Point of Care Diagnostic and Testing Forecast
10.1.5 Middle East & Africa Point of Care Diagnostic and Testing Forecast
10.2 Americas Point of Care Diagnostic and Testing Forecast by Country (2025-2030)
10.2.1 United States Point of Care Diagnostic and Testing Market Forecast
10.2.2 Canada Point of Care Diagnostic and Testing Market Forecast
10.2.3 Mexico Point of Care Diagnostic and Testing Market Forecast
10.2.4 Brazil Point of Care Diagnostic and Testing Market Forecast
10.3 APAC Point of Care Diagnostic and Testing Forecast by Region (2025-2030)
10.3.1 China Point of Care Diagnostic and Testing Market Forecast
10.3.2 Japan Point of Care Diagnostic and Testing Market Forecast
10.3.3 Korea Point of Care Diagnostic and Testing Market Forecast
10.3.4 Southeast Asia Point of Care Diagnostic and Testing Market Forecast
10.3.5 India Point of Care Diagnostic and Testing Market Forecast
10.3.6 Australia Point of Care Diagnostic and Testing Market Forecast
10.4 Europe Point of Care Diagnostic and Testing Forecast by Country (2025-2030)
10.4.1 Germany Point of Care Diagnostic and Testing Market Forecast
10.4.2 France Point of Care Diagnostic and Testing Market Forecast
10.4.3 UK Point of Care Diagnostic and Testing Market Forecast
10.4.4 Italy Point of Care Diagnostic and Testing Market Forecast
10.4.5 Russia Point of Care Diagnostic and Testing Market Forecast
10.5 Middle East & Africa Point of Care Diagnostic and Testing Forecast by Region (2025-2030)
10.5.1 Egypt Point of Care Diagnostic and Testing Market Forecast
10.5.2 South Africa Point of Care Diagnostic and Testing Market Forecast
10.5.3 Israel Point of Care Diagnostic and Testing Market Forecast
10.5.4 Turkey Point of Care Diagnostic and Testing Market Forecast
10.5.5 GCC Countries Point of Care Diagnostic and Testing Market Forecast
10.6 Global Point of Care Diagnostic and Testing Forecast by Type (2025-2030)
10.7 Global Point of Care Diagnostic and Testing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Information
11.1.2 F. Hoffmann-La Roche Point of Care Diagnostic and Testing Product Offered
11.1.3 F. Hoffmann-La Roche Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 F. Hoffmann-La Roche Main Business Overview
11.1.5 F. Hoffmann-La Roche Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Point of Care Diagnostic and Testing Product Offered
11.2.3 Qiagen Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Danaher
11.3.1 Danaher Company Information
11.3.2 Danaher Point of Care Diagnostic and Testing Product Offered
11.3.3 Danaher Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Danaher Main Business Overview
11.3.5 Danaher Latest Developments
11.4 Becton Dickinson and Company
11.4.1 Becton Dickinson and Company Company Information
11.4.2 Becton Dickinson and Company Point of Care Diagnostic and Testing Product Offered
11.4.3 Becton Dickinson and Company Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Becton Dickinson and Company Main Business Overview
11.4.5 Becton Dickinson and Company Latest Developments
11.5 Biomerieux
11.5.1 Biomerieux Company Information
11.5.2 Biomerieux Point of Care Diagnostic and Testing Product Offered
11.5.3 Biomerieux Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Biomerieux Main Business Overview
11.5.5 Biomerieux Latest Developments
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Company Information
11.6.2 Siemens Healthcare Point of Care Diagnostic and Testing Product Offered
11.6.3 Siemens Healthcare Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Siemens Healthcare Main Business Overview
11.6.5 Siemens Healthcare Latest Developments
11.7 Zoetis
11.7.1 Zoetis Company Information
11.7.2 Zoetis Point of Care Diagnostic and Testing Product Offered
11.7.3 Zoetis Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Zoetis Main Business Overview
11.7.5 Zoetis Latest Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Point of Care Diagnostic and Testing Product Offered
11.8.3 Abbott Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Abbott Main Business Overview
11.8.5 Abbott Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Point of Care Diagnostic and Testing Product Offered
11.9.3 Bayer Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Johnson and Johnson
11.10.1 Johnson and Johnson Company Information
11.10.2 Johnson and Johnson Point of Care Diagnostic and Testing Product Offered
11.10.3 Johnson and Johnson Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Johnson and Johnson Main Business Overview
11.10.5 Johnson and Johnson Latest Developments
11.11 Nova Biomedical
11.11.1 Nova Biomedical Company Information
11.11.2 Nova Biomedical Point of Care Diagnostic and Testing Product Offered
11.11.3 Nova Biomedical Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Nova Biomedical Main Business Overview
11.11.5 Nova Biomedical Latest Developments
11.12 Trividia Health
11.12.1 Trividia Health Company Information
11.12.2 Trividia Health Point of Care Diagnostic and Testing Product Offered
11.12.3 Trividia Health Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Trividia Health Main Business Overview
11.12.5 Trividia Health Latest Developments
11.13 Quidel Corporation
11.13.1 Quidel Corporation Company Information
11.13.2 Quidel Corporation Point of Care Diagnostic and Testing Product Offered
11.13.3 Quidel Corporation Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Quidel Corporation Main Business Overview
11.13.5 Quidel Corporation Latest Developments
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Information
11.14.2 Trinity Biotech Point of Care Diagnostic and Testing Product Offered
11.14.3 Trinity Biotech Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Trinity Biotech Main Business Overview
11.14.5 Trinity Biotech Latest Developments
11.15 Sekisui Diagnostics
11.15.1 Sekisui Diagnostics Company Information
11.15.2 Sekisui Diagnostics Point of Care Diagnostic and Testing Product Offered
11.15.3 Sekisui Diagnostics Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Sekisui Diagnostics Main Business Overview
11.15.5 Sekisui Diagnostics Latest Developments
11.16 Orasure Technologies
11.16.1 Orasure Technologies Company Information
11.16.2 Orasure Technologies Point of Care Diagnostic and Testing Product Offered
11.16.3 Orasure Technologies Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Orasure Technologies Main Business Overview
11.16.5 Orasure Technologies Latest Developments
11.17 Nipro
11.17.1 Nipro Company Information
11.17.2 Nipro Point of Care Diagnostic and Testing Product Offered
11.17.3 Nipro Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Nipro Main Business Overview
11.17.5 Nipro Latest Developments
11.18 Spectral Medical
11.18.1 Spectral Medical Company Information
11.18.2 Spectral Medical Point of Care Diagnostic and Testing Product Offered
11.18.3 Spectral Medical Point of Care Diagnostic and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Spectral Medical Main Business Overview
11.18.5 Spectral Medical Latest Developments
12 Research Findings and Conclusion

Table 1. Point of Care Diagnostic and Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Device
Table 3. Major Players of Consumables
Table 4. Major Players of Others
Table 5. Point of Care Diagnostic and Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Point of Care Diagnostic and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Point of Care Diagnostic and Testing Market Size Market Share by Type (2019-2024)
Table 8. Point of Care Diagnostic and Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Point of Care Diagnostic and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Point of Care Diagnostic and Testing Market Size Market Share by Application (2019-2024)
Table 11. Global Point of Care Diagnostic and Testing Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Point of Care Diagnostic and Testing Revenue Market Share by Player (2019-2024)
Table 13. Point of Care Diagnostic and Testing Key Players Head office and Products Offered
Table 14. Point of Care Diagnostic and Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Point of Care Diagnostic and Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Point of Care Diagnostic and Testing Market Size Market Share by Regions (2019-2024)
Table 19. Global Point of Care Diagnostic and Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Point of Care Diagnostic and Testing Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Point of Care Diagnostic and Testing Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Point of Care Diagnostic and Testing Market Size Market Share by Country (2019-2024)
Table 23. Americas Point of Care Diagnostic and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Point of Care Diagnostic and Testing Market Size Market Share by Type (2019-2024)
Table 25. Americas Point of Care Diagnostic and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Point of Care Diagnostic and Testing Market Size Market Share by Application (2019-2024)
Table 27. APAC Point of Care Diagnostic and Testing Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Point of Care Diagnostic and Testing Market Size Market Share by Region (2019-2024)
Table 29. APAC Point of Care Diagnostic and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Point of Care Diagnostic and Testing Market Size Market Share by Type (2019-2024)
Table 31. APAC Point of Care Diagnostic and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Point of Care Diagnostic and Testing Market Size Market Share by Application (2019-2024)
Table 33. Europe Point of Care Diagnostic and Testing Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Point of Care Diagnostic and Testing Market Size Market Share by Country (2019-2024)
Table 35. Europe Point of Care Diagnostic and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Point of Care Diagnostic and Testing Market Size Market Share by Type (2019-2024)
Table 37. Europe Point of Care Diagnostic and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Point of Care Diagnostic and Testing Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Point of Care Diagnostic and Testing Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Point of Care Diagnostic and Testing Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Point of Care Diagnostic and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Point of Care Diagnostic and Testing Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Point of Care Diagnostic and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Point of Care Diagnostic and Testing Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Point of Care Diagnostic and Testing
Table 46. Key Market Challenges & Risks of Point of Care Diagnostic and Testing
Table 47. Key Industry Trends of Point of Care Diagnostic and Testing
Table 48. Global Point of Care Diagnostic and Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Point of Care Diagnostic and Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Point of Care Diagnostic and Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Point of Care Diagnostic and Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. F. Hoffmann-La Roche Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 53. F. Hoffmann-La Roche Point of Care Diagnostic and Testing Product Offered
Table 54. F. Hoffmann-La Roche Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. F. Hoffmann-La Roche Main Business
Table 56. F. Hoffmann-La Roche Latest Developments
Table 57. Qiagen Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 58. Qiagen Point of Care Diagnostic and Testing Product Offered
Table 59. Qiagen Main Business
Table 60. Qiagen Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Qiagen Latest Developments
Table 62. Danaher Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 63. Danaher Point of Care Diagnostic and Testing Product Offered
Table 64. Danaher Main Business
Table 65. Danaher Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Danaher Latest Developments
Table 67. Becton Dickinson and Company Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 68. Becton Dickinson and Company Point of Care Diagnostic and Testing Product Offered
Table 69. Becton Dickinson and Company Main Business
Table 70. Becton Dickinson and Company Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Becton Dickinson and Company Latest Developments
Table 72. Biomerieux Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 73. Biomerieux Point of Care Diagnostic and Testing Product Offered
Table 74. Biomerieux Main Business
Table 75. Biomerieux Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Biomerieux Latest Developments
Table 77. Siemens Healthcare Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 78. Siemens Healthcare Point of Care Diagnostic and Testing Product Offered
Table 79. Siemens Healthcare Main Business
Table 80. Siemens Healthcare Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Siemens Healthcare Latest Developments
Table 82. Zoetis Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 83. Zoetis Point of Care Diagnostic and Testing Product Offered
Table 84. Zoetis Main Business
Table 85. Zoetis Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Zoetis Latest Developments
Table 87. Abbott Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 88. Abbott Point of Care Diagnostic and Testing Product Offered
Table 89. Abbott Main Business
Table 90. Abbott Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Abbott Latest Developments
Table 92. Bayer Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 93. Bayer Point of Care Diagnostic and Testing Product Offered
Table 94. Bayer Main Business
Table 95. Bayer Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Bayer Latest Developments
Table 97. Johnson and Johnson Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 98. Johnson and Johnson Point of Care Diagnostic and Testing Product Offered
Table 99. Johnson and Johnson Main Business
Table 100. Johnson and Johnson Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Johnson and Johnson Latest Developments
Table 102. Nova Biomedical Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 103. Nova Biomedical Point of Care Diagnostic and Testing Product Offered
Table 104. Nova Biomedical Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Nova Biomedical Main Business
Table 106. Nova Biomedical Latest Developments
Table 107. Trividia Health Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 108. Trividia Health Point of Care Diagnostic and Testing Product Offered
Table 109. Trividia Health Main Business
Table 110. Trividia Health Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Trividia Health Latest Developments
Table 112. Quidel Corporation Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 113. Quidel Corporation Point of Care Diagnostic and Testing Product Offered
Table 114. Quidel Corporation Main Business
Table 115. Quidel Corporation Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Quidel Corporation Latest Developments
Table 117. Trinity Biotech Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 118. Trinity Biotech Point of Care Diagnostic and Testing Product Offered
Table 119. Trinity Biotech Main Business
Table 120. Trinity Biotech Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Trinity Biotech Latest Developments
Table 122. Sekisui Diagnostics Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 123. Sekisui Diagnostics Point of Care Diagnostic and Testing Product Offered
Table 124. Sekisui Diagnostics Main Business
Table 125. Sekisui Diagnostics Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Sekisui Diagnostics Latest Developments
Table 127. Orasure Technologies Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 128. Orasure Technologies Point of Care Diagnostic and Testing Product Offered
Table 129. Orasure Technologies Main Business
Table 130. Orasure Technologies Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Orasure Technologies Latest Developments
Table 132. Nipro Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 133. Nipro Point of Care Diagnostic and Testing Product Offered
Table 134. Nipro Main Business
Table 135. Nipro Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Nipro Latest Developments
Table 137. Spectral Medical Details, Company Type, Point of Care Diagnostic and Testing Area Served and Its Competitors
Table 138. Spectral Medical Point of Care Diagnostic and Testing Product Offered
Table 139. Spectral Medical Main Business
Table 140. Spectral Medical Point of Care Diagnostic and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Spectral Medical Latest Developments
List of

Figure 1. Point of Care Diagnostic and Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Point of Care Diagnostic and Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Point of Care Diagnostic and Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Point of Care Diagnostic and Testing Sales Market Share by Country/Region (2023)
Figure 8. Point of Care Diagnostic and Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Point of Care Diagnostic and Testing Market Size Market Share by Type in 2023
Figure 10. Point of Care Diagnostic and Testing in Hospitals
Figure 11. Global Point of Care Diagnostic and Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Point of Care Diagnostic and Testing in Clinics
Figure 13. Global Point of Care Diagnostic and Testing Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Point of Care Diagnostic and Testing in Home
Figure 15. Global Point of Care Diagnostic and Testing Market: Home (2019-2024) & ($ Millions)
Figure 16. Point of Care Diagnostic and Testing in Others
Figure 17. Global Point of Care Diagnostic and Testing Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Point of Care Diagnostic and Testing Market Size Market Share by Application in 2023
Figure 19. Global Point of Care Diagnostic and Testing Revenue Market Share by Player in 2023
Figure 20. Global Point of Care Diagnostic and Testing Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Point of Care Diagnostic and Testing Market Size 2019-2024 ($ Millions)
Figure 22. APAC Point of Care Diagnostic and Testing Market Size 2019-2024 ($ Millions)
Figure 23. Europe Point of Care Diagnostic and Testing Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Point of Care Diagnostic and Testing Market Size 2019-2024 ($ Millions)
Figure 25. Americas Point of Care Diagnostic and Testing Value Market Share by Country in 2023
Figure 26. United States Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Point of Care Diagnostic and Testing Market Size Market Share by Region in 2023
Figure 31. APAC Point of Care Diagnostic and Testing Market Size Market Share by Type in 2023
Figure 32. APAC Point of Care Diagnostic and Testing Market Size Market Share by Application in 2023
Figure 33. China Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Point of Care Diagnostic and Testing Market Size Market Share by Country in 2023
Figure 40. Europe Point of Care Diagnostic and Testing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Point of Care Diagnostic and Testing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Point of Care Diagnostic and Testing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Point of Care Diagnostic and Testing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Point of Care Diagnostic and Testing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Point of Care Diagnostic and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 56. APAC Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 57. Europe Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 59. United States Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 60. Canada Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 63. China Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 64. Japan Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 65. Korea Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 67. India Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 68. Australia Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 69. Germany Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 70. France Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 71. UK Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 72. Italy Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 73. Russia Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 74. Spain Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 77. Israel Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Point of Care Diagnostic and Testing Market Size 2025-2030 ($ Millions)
Figure 80. Global Point of Care Diagnostic and Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Point of Care Diagnostic and Testing Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted